FoxO1, A2M, and TGF-β1: three novel genes predicting depression in gene X environment interactions are identified using cross-species and cross-tissues transcriptomic and miRNomic analyses

Molecular Psychiatry

Volumn 23, Issue 11, 2018, Pages 2192-2208

  Cattaneo, Annamaria ^a,b   Cattane, Nadia ^b   Malpighi, Chiara ^b   Czamara, Darina ^c   Suarez, Anna ^d   Mariani, Nicole ^a   Kajantie, Eero ^e,f,g   Luoni, Alessia ^h   Eriksson, Johan G ^e,i,j   Lahti, Jari ^d,e,f   Mondelli, Valeria ^a   Dazzan, Paola ^a   Räikkönen, Katri ^d   Binder, Elisabeth B ^c,k   Riva, Marco A ^h   Pariante, Carmine M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d UNIVERSITY OF HELSINKI   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^j OULU UNIVERSITY HOSPITAL   (Finland)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; MESSENGER RNA; MICRORNA; TRANSCRIPTION FACTOR FKHR; TRANSFORMING GROWTH FACTOR BETA1; A2M PROTEIN, HUMAN; FOXO1 PROTEIN, HUMAN; NERVE PROTEIN; TRANSCRIPTOME;

ADULT; ALPHA 2 MACROGLOBULIN GENE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; EARLY LIFE STRESS; EMOTIONAL ABUSE; FEMALE; FORKHEAD BOX PROTEIN O1 GENE; GENOTYPE ENVIRONMENT INTERACTION; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; MALE; NONHUMAN; PHYSICAL ABUSE; PRENATAL STRESS; PRIORITY JOURNAL; RAT; SEXUAL ABUSE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTOMICS; TRANSFORMING GROWTH FACTOR BETA 1 GENE; ANIMAL; COHORT ANALYSIS; DISEASE MODEL; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; METABOLISM; MIDDLE AGED; PREGNANCY; PROCEDURES;

ADULT; ALPHA-MACROGLOBULINS; ANIMALS; COHORT STUDIES; DEPRESSION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD BOX PROTEIN O1; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; RATS; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA1;

EID: 85040045279     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/s41380-017-0002-4     Document Type: Article

References (106)

1. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry. 2000;157:1552–62
2. Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7
3. Gaugler T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, et al. Most genetic risk for autism resides with common variation. Nat Genet. 2014;46:881–5
4. Nurnberger JI Jr., Koller DL, Jung J, Edenberg HJ, Foroud T, Guella I, et al. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry. 2014;71:657–64
5. Cross-Disorder Group of the Psychiatric Genomics C, Lee SH, Ripke S, Neale BM, Faraone SV, Purcell SM, et al. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984–94
6. Major Depressive Disorder Working Group of the Psychiatric GC, Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, et al. A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry. 2013;18: 497–511
7. Hyde CL, Nagle MW, Tian C, Chen X, Paciga SA, Wendland JR, et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat Genet. 2016;48:1031–6
8. Heim C, Binder EB. Current research trends in early life stress and depression: review of human studies on sensitive periods, gene-environment interactions, and epigenetics. Exp Neurol. 2012;233:102–11
9. Szyf M. The early life social environment and DNA methylation: DNA methylation mediating the long-term impact of social environments early in life. Epigenetics. 2011;6:971–8
10. Chapman DP, Whitfield CL, Felitti VJ, Dube SR, Edwards VJ, Anda RF. Adverse childhood experiences and the risk of depressive disorders in adulthood. J Affect Disord. 2004;82: 217–25
11. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–9
12. Munafo MR, Durrant C, Lewis G, Flint J. Gene X environment interactions at the serotonin transporter locus. Biol Psychiatry. 2009;65:211–9
13. Uher R, Caspi A, Houts R, Sugden K, Williams B, Poulton R, et al. Serotonin transporter gene moderates childhood maltreatment’s effects on persistent but not single-episode depression: replications and implications for resolving inconsistent results. J Affect Disord. 2011;135:56–65
14. Culverhouse RC, Saccone NL, Horton AC, Ma Y, Anstey KJ, Banaschewski T et al. Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. Mol Psychiatry. 2017; doi: 10.1038/mp.2017.44, Epub ahead of print
15. Zannas AS, Wiechmann T, Gassen NC, Binder EB. Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications. Neuropsychopharmacol. 2016;41:261–74
16. Comasco E, Gustafsson PA, Sydsjo G, Agnafors S, Aho N, Svedin CG. Psychiatric symptoms in adolescents: FKBP5 genotype-early life adversity interaction effects. Eur Child Adolesc Psychiatry. 2015;24:1473–83
17. Kohrt BA, Worthman CM, Ressler KJ, Mercer KB, Upadhaya N, Koirala S, et al. Cross-cultural gene- environment interactions in depression, post-traumatic stress disorder, and the cortisol awakening response: FKBP5 polymorphisms and childhood trauma in South Asia. Int Rev Psychiatry. 2015;27:180–96
18. Tozzi L, Carballedo A, Wetterling F, McCarthy H, O’Keane V, Gill M, et al. Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression. Neuropsychopharmacol. 2016;41:487–97
19. Lahti J, Ala-Mikkula H, Kajantie E, Haljas K, Eriksson JG, Raikkonen K. Associations Between Self-Reported and Objectively Recorded Early Life Stress, FKBP5 Polymorphisms, and Depressive Symptoms in Midlife. Biol Psychiatry. 2015;80: 869–77
20. Hohne N, Poidinger M, Merz F, Pfister H, Bruckl T, Zimmermann P, et al. FKBP5 genotype-dependent DNA methylation and mRNA regulation after psychosocial stress in remitted depression and healthy controls. Int J Neuropsychopharmacol. 2014;18:pyu087
21. Klengel T, Pape J, Binder EB, Mehta D. The role of DNA methylation in stress-related psychiatric disorders. Neuropharmacology. 2014;80:115–32
22. Dunn EC, Wiste A, Radmanesh F, Almli LM, Gogarten SM, Sofer T, et al. Genome-Wide Association Study (Gwas) and Genome-Wide by Environment Interaction Study (Gweis) of Depressive Symptoms in African American and Hispanic/Latina Women. Depress Anxiety. 2016;33:265–80
23. Otowa T, Kawamura Y, Tsutsumi A, Kawakami N, Kan C, Shimada T, et al. The First Pilot Genome-Wide Gene-Environment Study of Depression in the Japanese Population. PloS One. 2016;11:e0160823
24. Luoni A, Rocha FF, Riva MA. Anatomical specificity in the modulation of activity-regulated genes after acute or chronic lurasidone treatment. Progress neuro-Psychopharmacol Biol Psychiatry. 2014;50:94–101
25. Almli LM, Srivastava A, Fani N, Kerley K, Mercer KB, Feng H, et al. Follow-up and extension of a prior genome-wide association study of posttraumatic stress disorder: gene x environment associations and structural magnetic resonance imaging in a highly traumatized African-American civilian population. Biol Psychiatry. 2014;76:e3–e4
26. Barker DJ, Osmond C, Forsen TJ, Kajantie E, Eriksson JG. Trajectories of growth among children who have coronary events as adults. New Engl J Med. 2005;353:1802–9
27. Eriksson JG, Osmond C, Kajantie E, Forsen TJ, Barker DJ. Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia. 2006;49:2853–8
28. Anacker C, Cattaneo A, Luoni A, Musaelyan K, Zunszain PA, Milanesi E, et al. Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis. Neuropsychopharmacol. 2013;38:872–83
29. Anacker C, O’Donnell KJ, Meaney MJ. Early life adversity and the epigenetic programming of hypothalamic-pituitary-adrenal function. Dialog- Clin Neurosci. 2014;16:321–33
30. Luoni A, Macchi F, Papp M, Molteni R, Riva MA. Lurasidone exerts antidepressant properties in the chronic mild stress model through the regulation of synaptic and neuroplastic mechanisms in the rat prefrontal cortex. Int J Neuropsychopharmacol/Off Sci J Coll Int Neuropsychopharmacol. 2015;18:pyu061
31. Bifulco A, Bernazzani O, Moran PM, Jacobs C. The childhood experience of care and abuse questionnaire (CECA.Q): validation in a community series. Br J Clin Psychol. 2005;44(Pt 4):563–81
32. Bernstein DP, Stein JA, Handelsman L. Predicting personality pathology among adult patients with substance use disorders: effects of childhood maltreatment. Addict Behav. 1998;23:855–68
33. Bradley RG, Binder EB, Epstein MP, Tang Y, Nair HP, Liu W, et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch General Psychiatry. 2008;65:190–200
34. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch General Psychiatry. 1961;4:561–71
35. Rikkonen K, Pesonen AK, Heinonen K, Lahti J, Kajantie E, Forsen T, et al. Infant growth and hostility in adult life. Psychosom Med. 2008;70:306–13
36. Pesonen AK, Raikkonen K, Heinonen K, Kajantie E, Forsen T, Eriksson JG. Depressive symptoms in adults separated from their parents as children: a natural experiment during World War II. Am J Epidemiol. 2007;166:1126–33
37. Raikkonen K, Lahti M, Heinonen K, Pesonen AK, Wahlbeck K, Kajantie E, et al. Risk of severe mental disorders in adults separated temporarily from their parents in childhood: the Helsinki birth cohort study. J Psychiatr Res. 2011;45:332–8
38. Lahti J, Raikkonen K, Bruce S, Heinonen K, Pesonen AK, Rautanen A, et al. Glucocorticoid receptor gene haplotype predicts increased risk of hospital admission for depressive disorders in the Helsinki birth cohort study. J Psychiatr Res. 2011;45:1160–4
39. Pesonen AK, Raikkonen K, Feldt K, Heinonen K, Osmond C, Phillips DI, et al. Childhood separation experience predicts HPA axis hormonal responses in late adulthood: a natural experiment of World War II. Psychoneuroendocrinology. 2010;35:758–67
40. Hepgul N, Cattaneo A, Agarwal K, Baraldi S, Borsini A, Bufalino C, et al. Transcriptomics in Interferon-alpha-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression. Neuropsychopharmacol. 2016;41:2502–11
41. Fury W, Batliwalla F, Gregersen PK, Li W. Overlapping probabilities of top ranking gene lists, hypergeometric distribution, and stringency of gene selection criterion. Conf Proc. 2006;1:5531–4
42. Keller MC. Gene x environment interaction studies have not properly controlled for potential confounders: the problem and the (simple) solution. Biol Psychiatry. 2014;75:18–24
43. Yuen EY, Liu W, Karatsoreos IN, Ren Y, Feng J, McEwen BS, et al. Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol Psychiatry. 2011;16:156–70
44. Anacker C, Cattaneo A, Musaelyan K, Zunszain PA, Horowitz M, Molteni R, et al. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc Natl Acad Sci USA. 2013;110:8708–13
45. Maes M, Anderson G, Kubera M, Berk M. Targeting classical IL-6 signalling or IL-6 trans-signalling in depression? Expert Opin Ther Targets. 2014;18:495–512
46. Bersani FS, Wolkowitz OM, Lindqvist D, Yehuda R, Flory J, Bierer LM, et al. Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation. Brain, Behav, Immun. 2016;52:153–60
47. Carpenter LL, Gawuga CE, Tyrka AR, Lee JK, Anderson GM, Price LH. Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults. Neuropsychopharmacol. 2010;35:2617–23
48. Becking K, Boschloo L, Vogelzangs N, Haarman BC. Riemersma-van der Lek R, Penninx BW et al. The association between immune activation and manic symptoms in patients with a depressive disorder. Transl Psychiatry. 2013;3:e314
49. Rotter A, Biermann T, Stark C, Decker A, Demling J, Zimmermann R, et al. Changes of cytokine profiles during electroconvulsive therapy in patients with major depression. J ECT. 2013;29:162–9
50. Karg K, Burmeister M, Shedden K, Sen S. The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch General Psychiatry. 2011;68:444–54
51. Brown GW, Ban M, Craig TK, Harris TO, Herbert J, Uher R. Serotonin transporter length polymorphism, childhood maltreatment, and chronic depression: a specific gene-environment interaction. Depress Anxiety. 2013;30:5–13
52. Fisher HL, Cohen-Woods S, Hosang GM, Korszun A, Owen M, Craddock N, et al. Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder. J Affect Disord. 2013;145:136–41
53. Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry. 2005;10:220–4
54. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. Jama. 2009;301:2462–71
55. Duncan LE, Keller MC. A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry. Am J Psychiatry. 2011;168:1041–9
56. Uher R. Gene-environment interactions in severe mental illness. Front Psychiatry. 2014;5:48
57. Webb C, Gunn JM, Potiriadis M, Everall IP, Bousman CA. The Brain-Derived Neurotrophic Factor Val66Met Polymorphism Moderates the Effects of Childhood Abuse on Severity of Depressive Symptoms in a Time-Dependent Manner. Front Psychiatry. 2016;7:151
58. Gatt JM, Nemeroff CB, Dobson-Stone C, Paul RH, Bryant RA, Schofield PR, et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Psychiatry. 2009;14:681–95
59. Tabak BA, Vrshek-Schallhorn S, Zinbarg RE, Prenoveau JM, Mineka S, Redei EE, et al. Interaction of CD38 Variant and Chronic Interpersonal Stress Prospectively Predicts Social Anxiety and Depression Symptoms Over Six Years. Clin Psychol Sci. 2016;4:17–27
60. Lowe SR, Pothen J, Quinn JW, Rundle A, Bradley B, Galea S, et al. Gene-by-social-environment interaction (GxSE) between ADCYAP1R1 genotype and neighborhood crime predicts major depression symptoms in trauma-exposed women. J Affect Disord. 2015;187:147–50
61. Zhang JP, Robinson DG, Gallego JA, John M, Yu J, Addington J, et al. Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis. Schizophr Bull. 2015;41:1248–55
62. Sokolowski M, Ben-Efraim YJ, Wasserman J, Wasserman D. Glutamatergic GRIN2B and polyaminergic ODC1 genes in suicide attempts: associations and gene-environment interactions with childhood/adolescent physical assault. Mol Psychiatry. 2013;18:985–92
63. Mamdani M, Williamson V, McMichael GO, Blevins T, Aliev F, Adkins A, et al. Integrating mRNA and miRNA Weighted Gene Co-Expression Networks with eQTLs in the Nucleus Accumbens of Subjects with Alcohol Dependence. PloS One. 2015;10:e0137671
64. Wang XW, Yu Y, Gu L. Dehydroabietic acid reverses TNF-alpha-induced the activation of FOXO1 and suppression of TGF-beta1/Smad signaling in human adult dermal fibroblasts. Int J Clin Exp Pathol. 2014;7:8616–26
65. Kaiser G, Gerst F, Michael D, Berchtold S, Friedrich B, Strutz-Seebohm N, et al. Regulation of forkhead box O1 (FOXO1) by protein kinase B and glucocorticoids: different mechanisms of induction of beta cell death in vitro. Diabetologia. 2013;56: 1587–95
66. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY, et al. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell. 2004;117:225–37
67. Mahmud DL, M GA, Deb DK, Platanias LC, Uddin S, Wickrema A. Phosphorylation of forkhead transcription factors by erythropoietin and stem cell factor prevents acetylation and their interaction with coactivator p300 in erythroid progenitor cells. Oncogene. 2002;21:1556–62
68. Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 2004;23:4802–12
69. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999;96:857–68
70. Kops GJ, Burgering BM. Forkhead transcription factors: new insights into protein kinase B (c-akt) signaling. J Mol Med. 1999;77:656–65
71. Feroze-Zaidi F, Fusi L, Takano M, Higham J, Salker MS, Goto T, et al. Role and regulation of the serum- and glucocorticoid-regulated kinase 1 in fertile and infertile human endometrium. Endocrinology. 2007;148:5020–9
72. Di Pietro N, Panel V, Hayes S, Bagattin A, Meruvu S, Pandolfi A, et al. Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via forkhead box O1. Mol Endocrinol. 2010;24:370–80
73. Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 2004;117: 421–6
74. Hoekman MF, Jacobs FM, Smidt MP, Burbach JP. Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain. Gene Expr Pattern. 2006;6: 134–40
75. Wang H, Quirion R, Little PJ, Cheng Y, Feng ZP, Sun HS, et al. Forkhead box O transcription factors as possible mediators in the development of major depression. Neuropharmacology. 2015;99: 527–37
76. Magno LA, Santana CV, Sacramento EK, Rezende VB, Cardoso MV, Mauricio-da-Silva L, et al. Genetic variations in FOXO3A are associated with Bipolar Disorder without confering vulnerability for suicidal behavior. J Affect Disord. 2011;133:633–7
77. Zhou J, Liao W, Yang J, Ma K, Li X, Wang Y, et al. FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway. Autophagy. 2012;8:1712–23
78. Polter A, Yang S, Zmijewska AA, van Groen T, Paik JH, Depinho RA, et al. Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation. Biol Psychiatry. 2009;65:150–9
79. Hope C, Mettenburg J, Gonias SL, DeKosky ST, Kamboh MI, Chu CT. Functional analysis of plasma alpha(2)-macroglobulin from Alzheimer’s disease patients with the A2M intronic deletion. Neurobiol Dis. 2003;14:504–12
80. Bottner M, Krieglstein K, Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem. 2000;75:2227–40
81. Gomes FC, Sousa Vde O, Romao L. Emerging roles for TGF-beta1 in nervous system development. Int J Dev Neurosci: Off J Int Soc Dev Neurosci. 2005;23:413–24
82. Stipursky J, Francis D, Dezonne RS, Bergamo de Araujo AP, Souza L, Moraes CA, et al. TGF-beta1 promotes cerebral cortex radial glia-astrocyte differentiation in vivo. Front Cell Neurosci. 2014;8:393
83. Stipursky J, Francis D, Gomes FC. Activation of MAPK/PI3K/SMAD pathways by TGF-beta(1) controls differentiation of radial glia into astrocytes in vitro. Dev Neurosci. 2012;34:68–81
84. Fujita T, Nagayama A, Anazawa S. Circulating alpha-2-macroglobulin levels and depression scores in patients who underwent abdominal cancer surgery. J Surg Res. 2003;114: 90–94
85. Douxfils J, Lambert S, Mathieu C, Milla S, Mandiki SN, Henrotte E, et al. Influence of domestication process on immune response to repeated emersion stressors in Eurasian perch (Perca fluviatilis, L.). Comp Biochem Physiol Part A. 2014;173C: 52–60
86. Kodavanti UP, Andrews D, Schladweiler MC, Gavett SH, Dodd DE, Cyphert JM. Early and delayed effects of naturally occurring asbestos on serum biomarkers of inflammation and metabolism. J Toxicol Environ Health Part A. 2014;77:1024–39
87. Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, et al. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol. 2013;38:377–85
88. Cattaneo A, Ferrari C, Uher R, Bocchio-Chiavetto L, Riva MA. Consortium MRCI et al. Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-beta mRNA Levels Accurately Predict Treatment Response in Depressed Patients. The international journal of neuropsychopharmacology/official scientific journal of the Collegium Internationale Neuropsychopharmacologicum 2016; 19
89. Pallavi P, Sagar R, Mehta M, Sharma S, Subramanium A, Shamshi F, et al. Serum cytokines and anxiety in adolescent depression patients: Gender effect. Psychiatry Res. 2015;229: 374–80
90. Musil R, Schwarz MJ, Riedel M, Dehning S, Cerovecki A, Spellmann I, et al. Elevated macrophage migration inhibitory factor and decreased transforming growth factor-beta levels in major depression--no influence of celecoxib treatment. J Affect Disord. 2011;134:217–25
91. Lu S, Peng H, Wang L, Vasish S, Zhang Y, Gao W, et al. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis. Compr Psychiatry. 2013;54:953–61
92. Tenorio-Laranga J, Peltonen I, Keskitalo S, Duran-Torres G, Natarajan R, Mannisto PT, et al. Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome. Biochem Pharmacol. 2013;85:1783–94
93. Yang Q, Wang EY, Jia HW, Wang YP. Association between polymorphisms in transforming growth factor-beta1 and sporadic Alzheimer’s disease in a Chinese population. Int J Neurosci. 2016;126:979–84
94. Rodriguez-Rodriguez E, Sanchez-Juan P, Mateo I, Llorca J, Infante J, Garcia-Gorostiaga I, et al. Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer’s disease. Acta Neurol Scand. 2007;116:409–12
95. Vaiserman AM. Epigenetic programming by early-life stress: Evidence from human populations. Dev Dyn. 2015;244:254–65
96. Desplats PA. Perinatal programming of neurodevelopment: epigenetic mechanisms and the prenatal shaping of the brain. Adv Neurobiol. 2015;10:335–61
97. Provencal N, Binder EB. The neurobiological effects of stress as contributors to psychiatric disorders: focus on epigenetics. Curr Opin Neurobiol. 2015;30:31–37
98. Klengel T, Mehta D, Anacker C, Rex-Haffner M, Pruessner JC, Pariante CM, et al. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 2013;16:33–41
99. Gapp K, Jawaid A, Sarkies P, Bohacek J, Pelczar P, Prados J, et al. Implication of sperm RNAs in transgenerational inheritance of the effects of early trauma in mice. Nat Neurosci. 2014;17:667–9
100. Mannironi C, Camon J, De Vito F, Biundo A, De Stefano ME, Persiconi I, et al. Acute stress alters amygdala microRNA miR-135a and miR-124 expression: inferences for corticosteroid dependent stress response. PloS One. 2013;8:e73385
101. Schouten M, Aschrafi A, Bielefeld P, Doxakis E, Fitzsimons CP. microRNAs and the regulation of neuronal plasticity under stress conditions. Neuroscience. 2013;241:188–205
102. Bai M, Zhu X, Zhang Y, Zhang S, Zhang L, Xue L, et al. Abnormal hippocampal BDNF and miR-16 expression is associated with depression-like behaviors induced by stress during early life. PloS One. 2012;7:e46921
103. Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs. Cell. 2009;136:642–55
104. Chekulaeva M, Filipowicz W. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol. 2009;21:452–60
105. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011;12:99–110
106. Ziats MN, Rennert OM. Identification of differentially expressed microRNAs across the developing human brain. Mol Psychiatry. 2014;19:848–52